Medical literature on infection rates for certain specific endourological procedures is available. However, literature is lacking in providing a comprehensive view of the overall post endoscopic infection rates and their risk factors. This article attempts to provide an understanding of overall bacteriuria rate and discuss the contributory factors for common endourological procedures performed in a dedicated urology unit. This was a retrospective analysis of all patients who underwent endourological procedures at our Institute between January 2019 and December 2019. The following factors were assessed as contributors to post-operative bacteriuria: gluteraldehyde versus plasma sterilization of endoscopic equipments, elective versus emergency procedures, age group, the presence of pre-operative foreign bodies, post-operative stent, chronic kidney disease (CKD), diabetes mellitus (DM), procedure time and American Society of Anaesthesiology (ASA) grades. The overall post-operative bacteriuria rate was 17.85% in our total study population, 6.37% had symptomatic urinary tract infection (UTI). Chronic kidney disease (OR 3.5, p < 0.003) and higher ASA grade (OR 1.92, P < 0.002) appear to confer the highest risk of bacteriuria. The factors which were associated with a trend towards a higher incidence of UTI without reaching statistical significance included: the use of gluteraldehyde versus plasma sterilization, pre-operative implants (Foley and ureteric stents), diabetes, advanced age, endoscopy time, post-operative stent emergency surgeries and a clinical decision against the use of prophylactic antibiotics. The overall rate of bacteriuria in all endourological procedures was 17.8%, 6.37% had symptomatic UTI. Chronic kidney disease and higher ASA grades were the most important contributing factors to develop post-operative bacteriuria.
关于某些特定泌尿道手术的感染率的医学文献是可用的。然而,文献缺乏提供整体内镜后感染率及其危险因素的综合观点。本文试图提供总体细菌率的理解,并讨论在专门的泌尿科单位进行的常见泌尿道手术的影响因素。这是对2019年1月至2019年12月期间在我们研究所接受泌尿系统手术的所有患者的回顾性分析。以下因素被评估为术后细菌尿的影响因素:内窥镜设备的gluter醛与血浆灭菌,选择性与紧急手术,年龄组,术前异物的存在,术后支架,慢性肾脏疾病(CKD),糖尿病(DM),手术时间和美国麻醉学会(ASA)分级。总研究人群术后细菌率为17.85%,有症状性尿路感染(UTI)为6.37%。慢性肾脏疾病(OR 3.5, p < 0.003)和较高的ASA分级(OR 1.92, p < 0.002)似乎具有最高的细菌尿风险。与尿路感染发生率升高趋势相关但未达到统计学意义的因素包括:使用谷戊醛与血浆灭菌、术前植入物(Foley和输尿管支架)、糖尿病、高龄、内镜检查时间、术后支架紧急手术和临床决定不使用预防性抗生素。所有泌尿系统手术中细菌尿的总发生率为17.8%,有症状性尿路感染的发生率为6.37%。慢性肾脏疾病和较高的ASA分级是发生术后细菌尿的最重要因素。
{"title":"An analysis of bacteriuria rates after endourological procedures","authors":"Nethravathy Billava Seenappa MSc, Maneesh Sinha MS, MCh, DNB, Thyagaraj Krishna Prasad MS, DNB, Venkatesh Krishnamoorthy MS, MCh, FRCS","doi":"10.1111/ijun.12331","DOIUrl":"10.1111/ijun.12331","url":null,"abstract":"<p>Medical literature on infection rates for certain specific endourological procedures is available. However, literature is lacking in providing a comprehensive view of the overall post endoscopic infection rates and their risk factors. This article attempts to provide an understanding of overall bacteriuria rate and discuss the contributory factors for common endourological procedures performed in a dedicated urology unit. This was a retrospective analysis of all patients who underwent endourological procedures at our Institute between January 2019 and December 2019. The following factors were assessed as contributors to post-operative bacteriuria: gluteraldehyde versus plasma sterilization of endoscopic equipments, elective versus emergency procedures, age group, the presence of pre-operative foreign bodies, post-operative stent, chronic kidney disease (CKD), diabetes mellitus (DM), procedure time and American Society of Anaesthesiology (ASA) grades. The overall post-operative bacteriuria rate was 17.85% in our total study population, 6.37% had symptomatic urinary tract infection (UTI). Chronic kidney disease (OR 3.5, <i>p</i> < 0.003) and higher ASA grade (OR 1.92, <i>P</i> < 0.002) appear to confer the highest risk of bacteriuria. The factors which were associated with a trend towards a higher incidence of UTI without reaching statistical significance included: the use of gluteraldehyde versus plasma sterilization, pre-operative implants (Foley and ureteric stents), diabetes, advanced age, endoscopy time, post-operative stent emergency surgeries and a clinical decision against the use of prophylactic antibiotics. The overall rate of bacteriuria in all endourological procedures was 17.8%, 6.37% had symptomatic UTI. Chronic kidney disease and higher ASA grades were the most important contributing factors to develop post-operative bacteriuria.</p>","PeriodicalId":50281,"journal":{"name":"International Journal of Urological Nursing","volume":"17 1","pages":"45-49"},"PeriodicalIF":0.5,"publicationDate":"2022-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48279761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Małgorzata Mazur PhD, Joanna Chorbińska MD, Łukasz Nowak MD, Urszula Halska MSc, Kinga Bańkowska MD, Aleksandra Sójka MD, Bartosz Małkiewicz MD, PhD, DSc, Romuald Zdrojowy MD, PhD, DSc, Anna Pałęga PhD, Tomasz Szydełko PhD, DSc, Wojciech Krajewski MD, PhD, DSc
Only limited data evaluating coping methods in patients with bladder cancer are available in the literature. Also, it is unclear how the mental status of these patients affects their stress coping strategies. The aim of the study was to evaluate the stress coping strategies in patients with non-muscle-invasive bladder cancer (NMIBC) and to assess the impact of sociodemographic factors, presence of anxiety and depressive symptoms and degree of sexual satisfaction on stress coping strategies. This prospective cohort study included 100 male patients qualified for control cystoscopy who underwent at least one transurethral resection of bladder tumour (TURB) procedure in the past for NMIBC and at least one control cystoscopy. The minimal follow-up period after primary TURB was 1 year. The MiniCOPE, the Hospital Anxiety and Depression Scale and the Sexual Satisfaction Questionnaire were used. The questionnaires were completed anonymously before cystoscopy in a room that provided privacy. Majority patients with NMIBC chosen adaptive strategies, with ‘accepting’ and ‘seeking emotional support’ being the most common. The choice of strategy was influenced by the severity of anxiety and depressive symptoms as well as the level of sexual satisfaction and pain sensations. Also, sociodemographic variables, such as marriage status, progeniture or the level of education played a role in strategy selection. The results of this study indicate that patients with NMIBC choose adaptive stress coping strategies. It also provides a better understanding of the impact of various aspects of mental health in patients with NMIBC on coping with stress. Each patient treated for NMIBC should undergo appropriate psychological and sociodemographic evaluation, which will allow easier identification of patients at high risk of treatment and postoperative surveillance discontinuation.
{"title":"Methods of coping with neoplastic disease in men with non-muscle-invasive bladder cancer","authors":"Małgorzata Mazur PhD, Joanna Chorbińska MD, Łukasz Nowak MD, Urszula Halska MSc, Kinga Bańkowska MD, Aleksandra Sójka MD, Bartosz Małkiewicz MD, PhD, DSc, Romuald Zdrojowy MD, PhD, DSc, Anna Pałęga PhD, Tomasz Szydełko PhD, DSc, Wojciech Krajewski MD, PhD, DSc","doi":"10.1111/ijun.12329","DOIUrl":"10.1111/ijun.12329","url":null,"abstract":"<p>Only limited data evaluating coping methods in patients with bladder cancer are available in the literature. Also, it is unclear how the mental status of these patients affects their stress coping strategies. The aim of the study was to evaluate the stress coping strategies in patients with non-muscle-invasive bladder cancer (NMIBC) and to assess the impact of sociodemographic factors, presence of anxiety and depressive symptoms and degree of sexual satisfaction on stress coping strategies. This prospective cohort study included 100 male patients qualified for control cystoscopy who underwent at least one transurethral resection of bladder tumour (TURB) procedure in the past for NMIBC and at least one control cystoscopy. The minimal follow-up period after primary TURB was 1 year. The MiniCOPE, the Hospital Anxiety and Depression Scale and the Sexual Satisfaction Questionnaire were used. The questionnaires were completed anonymously before cystoscopy in a room that provided privacy. Majority patients with NMIBC chosen adaptive strategies, with ‘accepting’ and ‘seeking emotional support’ being the most common. The choice of strategy was influenced by the severity of anxiety and depressive symptoms as well as the level of sexual satisfaction and pain sensations. Also, sociodemographic variables, such as marriage status, progeniture or the level of education played a role in strategy selection. The results of this study indicate that patients with NMIBC choose adaptive stress coping strategies. It also provides a better understanding of the impact of various aspects of mental health in patients with NMIBC on coping with stress. Each patient treated for NMIBC should undergo appropriate psychological and sociodemographic evaluation, which will allow easier identification of patients at high risk of treatment and postoperative surveillance discontinuation.</p>","PeriodicalId":50281,"journal":{"name":"International Journal of Urological Nursing","volume":"17 1","pages":"29-38"},"PeriodicalIF":0.5,"publicationDate":"2022-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48084826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Giulia Villa RN, PhD, Mattia Boarin RN, MScN, Debora Rosa RN, PhD, Serena Togni RN, PhD, Duilio F. Manara RN, Loris Bonetti RN, PhD, Stefano Terzoni RN, PhD
What is the state of knowledge on the use of phytotherapy in the following urological benign diseases: prostatic hyperplasia, erectile dysfunction, male infertility, urolithiasis and low-urinary tract symptoms? Supplements derived from natural products are used in medicine alone or in combination with drugs. In urology, there are many products used for symptom management in benign conditions. The aim of this review was to investigate the use of herbal medicines to treat benign urological diseases. A systematic review was conducted using the PubMed, CINAHL, Cochrane Library, Embase and Scopus (2010–2021) databases. The inclusion criteria were studies describing the use of phytotherapeutic strategies to treat adult patients with urological diseases. Quality assessments were performed using the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) approach. Nineteen studies were included in this systematic review: 13 randomized controlled trials, 3 pilot studies, 1 quasi-experimental study, 1 retrospective observational study and 1 post hoc analysis. Phytotherapeutic agents used to treat benign prostatic hyperplasia included royal jelly, Viola odorata, Echium amoenum, Physalis alkekengi, soy isoflavones, Serenoa repens, Trigonella foenum-graecum, lycopene and selenium. Tribulus terrestris is widely used to treat erectile dysfunction and male infertility. Lycopene, Korean ginseng berries, Indian ginseng and Curcuma improve sperm characteristics and motility. Lupeol therapy reduces kidney stone size, improving urolithiasis symptoms and accelerating the expulsion of small stones. No standard of care has been established for the use of phytotherapeutic agents to manage patients with symptomatic urological disorders. Although randomized controlled trials were the most common study type in our review, the sample sizes were limited, and the study duration and follow-up periods were often very short.
{"title":"Phytotherapy in urological benign disease: A systematic review","authors":"Giulia Villa RN, PhD, Mattia Boarin RN, MScN, Debora Rosa RN, PhD, Serena Togni RN, PhD, Duilio F. Manara RN, Loris Bonetti RN, PhD, Stefano Terzoni RN, PhD","doi":"10.1111/ijun.12328","DOIUrl":"10.1111/ijun.12328","url":null,"abstract":"<p>What is the state of knowledge on the use of phytotherapy in the following urological benign diseases: prostatic hyperplasia, erectile dysfunction, male infertility, urolithiasis and low-urinary tract symptoms? Supplements derived from natural products are used in medicine alone or in combination with drugs. In urology, there are many products used for symptom management in benign conditions. The aim of this review was to investigate the use of herbal medicines to treat benign urological diseases. A systematic review was conducted using the PubMed, CINAHL, Cochrane Library, Embase and Scopus (2010–2021) databases. The inclusion criteria were studies describing the use of phytotherapeutic strategies to treat adult patients with urological diseases. Quality assessments were performed using the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) approach. Nineteen studies were included in this systematic review: 13 randomized controlled trials, 3 pilot studies, 1 quasi-experimental study, 1 retrospective observational study and 1 post hoc analysis. Phytotherapeutic agents used to treat benign prostatic hyperplasia included royal jelly, <i>Viola odorata</i>, <i>Echium amoenum</i>, <i>Physalis alkekengi</i>, soy isoflavones, <i>Serenoa repens</i>, <i>Trigonella foenum-graecum</i>, lycopene and selenium. <i>Tribulus terrestris</i> is widely used to treat erectile dysfunction and male infertility. Lycopene, Korean ginseng berries, Indian ginseng and <i>Curcuma</i> improve sperm characteristics and motility. Lupeol therapy reduces kidney stone size, improving urolithiasis symptoms and accelerating the expulsion of small stones. No standard of care has been established for the use of phytotherapeutic agents to manage patients with symptomatic urological disorders. Although randomized controlled trials were the most common study type in our review, the sample sizes were limited, and the study duration and follow-up periods were often very short.</p>","PeriodicalId":50281,"journal":{"name":"International Journal of Urological Nursing","volume":"16 3","pages":"174-195"},"PeriodicalIF":0.5,"publicationDate":"2022-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48153554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jenniffer Puerta Suárez PhD, Walter Darío Cardona Maya PhD
The aim of the present study is to find the frequency of chronic prostatitis in Antioquia, Colombia. There are epidemiological gaps in this issue in the Colombian population. Chronic prostatitis is a prevalent disease with a high impact on life quality. The NIH-Chronic Prostatitis Symptom Index (NIH-CPSI) is a commonly used 13-item questionnaire to assess symptom severity in men with chronic prostatitis/chronic pelvic pain syndrome. A validated Spanish version of the NIH-CPSI questionnaire was distributed through social media and institutional e-mails from the University of Antioquia database and other institutions in the Metropolitan Area. Of the distributed questionnaires, 2022 were filled. The vast majority of participants were students, teachers, and professionals. A frequency of 16.4% chronic prostatitis symptoms was observed, 10.1% of individuals had severe symptoms with a median age of 32 years, accompanied by perineal pain and ejaculatory symptoms. Using the NIH-CPSI, the reported worldwide prevalence of chronic prostatitis is range between 1.8% and 65%. This report shows the disease's frequency in Colombia and Latin America for the first time. Chronic prostatitis is a frequent disease in the Antioquia population, with a high impact on the quality of life. Therefore, public health policies should be implemented focusing on men's health.
{"title":"Prostatitis-like symptoms in Antioquia, Colombia using the National Institute of Health-Chronic Prostatitis Symptom Index","authors":"Jenniffer Puerta Suárez PhD, Walter Darío Cardona Maya PhD","doi":"10.1111/ijun.12330","DOIUrl":"10.1111/ijun.12330","url":null,"abstract":"<p>The aim of the present study is to find the frequency of chronic prostatitis in Antioquia, Colombia. There are epidemiological gaps in this issue in the Colombian population. Chronic prostatitis is a prevalent disease with a high impact on life quality. The NIH-Chronic Prostatitis Symptom Index (NIH-CPSI) is a commonly used 13-item questionnaire to assess symptom severity in men with chronic prostatitis/chronic pelvic pain syndrome. A validated Spanish version of the NIH-CPSI questionnaire was distributed through social media and institutional e-mails from the University of Antioquia database and other institutions in the Metropolitan Area. Of the distributed questionnaires, 2022 were filled. The vast majority of participants were students, teachers, and professionals. A frequency of 16.4% chronic prostatitis symptoms was observed, 10.1% of individuals had severe symptoms with a median age of 32 years, accompanied by perineal pain and ejaculatory symptoms. Using the NIH-CPSI, the reported worldwide prevalence of chronic prostatitis is range between 1.8% and 65%. This report shows the disease's frequency in Colombia and Latin America for the first time. Chronic prostatitis is a frequent disease in the Antioquia population, with a high impact on the quality of life. Therefore, public health policies should be implemented focusing on men's health.</p>","PeriodicalId":50281,"journal":{"name":"International Journal of Urological Nursing","volume":"17 1","pages":"39-44"},"PeriodicalIF":0.5,"publicationDate":"2022-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43018849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
What are the experiences of post-prostatectomy cancer patients regarding self-management of lower urinary tract symptoms? Individuals with prostate cancer are required to self-manage their post-operative lower urinary tract symptoms and issues associated with them. Clarifying the various aspects of self-management can help in improving patient-tailored support. This study therefore aimed to clarify the self-management of lower urinary tract symptoms in prostate cancer patients who underwent total prostatectomy. Most post-prostatectomy cancer patients have multiple lower urinary tract symptoms. They have a reduced quality of life due to the symptoms and associated physical, psychological, and social issues. Self-management of the symptoms in uncomplicated cases has been shown to be effective, but this has not been clarified for post-prostatectomy cancer patients. The study setting consisted of two designated cancer centres. A survey with semi-structured interviews was conducted among 13 patients with prostate cancer that underwent total prostatectomy. Data were analysed using the qualitative content analysis techniques of Mayring. A total of 410 codes were extracted from which 42 subcategories and 10 categories emerged. The categories were: (1) recognition of issues associated with lower urinary tract symptoms to be solved; (2) examination of strategies for coping with these symptoms; (3) incorporation of actions that lead to an improvement in the symptoms; (4) avoidance of behaviours that cause worsening of the symptoms; (5) devising ways to prevent interference with one's daily life; (6) dealing with problems associated with the symptoms; (7) building relationships with medical staff and surroundings; (8) self-evaluation of bladder control status; (9) positive acceptance of the symptoms; and (10) sensing the effectiveness of strategies regarding the control of urination. The results suggest that health care professionals need to provide feedback to patients on LUTS strategies and their effects to help support patient coping strategies. In addition, determining individual patients' strengths and deficiencies in self-management will allow us to tailor assistance to patients. This is the first step towards the development of self-management scales to objectively assess self-management.
{"title":"Self-management of lower urinary tract symptoms in post-prostatectomy cancer patients: Content analysis","authors":"Koji Amano MN, Kumi Suzuki PhD","doi":"10.1111/ijun.12327","DOIUrl":"https://doi.org/10.1111/ijun.12327","url":null,"abstract":"<p>What are the experiences of post-prostatectomy cancer patients regarding self-management of lower urinary tract symptoms? Individuals with prostate cancer are required to self-manage their post-operative lower urinary tract symptoms and issues associated with them. Clarifying the various aspects of self-management can help in improving patient-tailored support. This study therefore aimed to clarify the self-management of lower urinary tract symptoms in prostate cancer patients who underwent total prostatectomy. Most post-prostatectomy cancer patients have multiple lower urinary tract symptoms. They have a reduced quality of life due to the symptoms and associated physical, psychological, and social issues. Self-management of the symptoms in uncomplicated cases has been shown to be effective, but this has not been clarified for post-prostatectomy cancer patients. The study setting consisted of two designated cancer centres. A survey with semi-structured interviews was conducted among 13 patients with prostate cancer that underwent total prostatectomy. Data were analysed using the qualitative content analysis techniques of Mayring. A total of 410 codes were extracted from which 42 subcategories and 10 categories emerged. The categories were: (1) recognition of issues associated with lower urinary tract symptoms to be solved; (2) examination of strategies for coping with these symptoms; (3) incorporation of actions that lead to an improvement in the symptoms; (4) avoidance of behaviours that cause worsening of the symptoms; (5) devising ways to prevent interference with one's daily life; (6) dealing with problems associated with the symptoms; (7) building relationships with medical staff and surroundings; (8) self-evaluation of bladder control status; (9) positive acceptance of the symptoms; and (10) sensing the effectiveness of strategies regarding the control of urination. The results suggest that health care professionals need to provide feedback to patients on LUTS strategies and their effects to help support patient coping strategies. In addition, determining individual patients' strengths and deficiencies in self-management will allow us to tailor assistance to patients. This is the first step towards the development of self-management scales to objectively assess self-management.</p>","PeriodicalId":50281,"journal":{"name":"International Journal of Urological Nursing","volume":"16 3","pages":"234-244"},"PeriodicalIF":0.5,"publicationDate":"2022-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91942144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Fatma Aslan Demirtaş MSN, Fatma Başar PhD, Yılda Arzu Aba PhD
This study was conducted to determine the effects of urinary symptoms and incontinence on quality of life in postmenopausal women. The sample of the cross-sectional study consisted of 327 women aged 50–65 who visited primary healthcare centers between 16 April and 30 July 2018. The data were collected using a personal information form, the Urinary Symptom Profile Questionnaire (USP) and the Incontinence Quality of Life Scale (I-QOL). The mean age of the women participating in the study was 57.89 ± 5.05. It was found that 50.5% of the women had a history of incontinence. While the total mean USP score of all women participating in the study was 4.94 ± 4.81, it was 7.98 ± 4.85 for the women with a history of incontinence. The mean total I-QOL score was 87.09 ± 16.04 in all women and 76.95 ± 16.93 in the women with a history of incontinence. The women with a history of incontinence were found to have a strong negative correlation between their total USP and total I-QOL scores. In this study, it was found that the quality of life of women with urinary incontinence, especially their psychosocial health, was found to be significantly affected.
{"title":"Urinary symptoms and incontinence in postmenopausal women and the effects on quality of life","authors":"Fatma Aslan Demirtaş MSN, Fatma Başar PhD, Yılda Arzu Aba PhD","doi":"10.1111/ijun.12322","DOIUrl":"10.1111/ijun.12322","url":null,"abstract":"<p>This study was conducted to determine the effects of urinary symptoms and incontinence on quality of life in postmenopausal women. The sample of the cross-sectional study consisted of 327 women aged 50–65 who visited primary healthcare centers between 16 April and 30 July 2018. The data were collected using a personal information form, the Urinary Symptom Profile Questionnaire (USP) and the Incontinence Quality of Life Scale (I-QOL). The mean age of the women participating in the study was 57.89 ± 5.05. It was found that 50.5% of the women had a history of incontinence. While the total mean USP score of all women participating in the study was 4.94 ± 4.81, it was 7.98 ± 4.85 for the women with a history of incontinence. The mean total I-QOL score was 87.09 ± 16.04 in all women and 76.95 ± 16.93 in the women with a history of incontinence. The women with a history of incontinence were found to have a strong negative correlation between their total USP and total I-QOL scores. In this study, it was found that the quality of life of women with urinary incontinence, especially their psychosocial health, was found to be significantly affected.</p>","PeriodicalId":50281,"journal":{"name":"International Journal of Urological Nursing","volume":"16 3","pages":"225-233"},"PeriodicalIF":0.5,"publicationDate":"2022-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43730755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}